Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Services-Commercial Physical & Biological Research

Standard Industrial Classification: SIC 8731

Industry Insider Sentiment Analysis

The Services-Commercial Physical & Biological Research sector (SIC 8731) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2024-03-01 00:11 2024-02-27 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $403.01 100,000 $40,300,500 5,133,019
2024-02-29 00:34 2024-02-26 MEDP Medpace Holdings, Inc. Keating Ashley M. Director OPT+S $404.29 500 $202,147 0
2024-02-29 00:30 2024-02-26 MXCT MAXCYTE, INC. Johnston John Joseph Director OPT+S $4.60 5,000 $23,005 120,583
2024-02-28 00:17 2024-02-23 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $401.07 156,928 $62,938,689 5,233,019
2024-02-28 00:09 2024-02-23 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $401.07 156,928 $62,938,689 5,233,019
2024-02-24 00:11 2024-02-21 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $392.66 136,012 $53,406,445 5,389,947
2024-02-24 00:15 2024-02-21 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $392.66 136,012 $53,406,445 5,389,947
2024-02-24 00:57 2024-02-22 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Barbo William D Officer SELL $248.50 4,050 $1,006,425 22,879
2024-02-22 00:45 2024-02-16 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $390.58 63,988 $24,992,324 5,525,959
2024-02-22 00:50 2024-02-16 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $390.58 63,988 $24,992,324 5,525,959
2024-02-22 01:08 2024-02-16 IQV IQVIA HOLDINGS INC. Sherbet Eric Officer SELL $241.50 1,000 $241,500 20,836
2024-02-22 01:07 2024-02-16 IQV IQVIA HOLDINGS INC. Knightly Kevin C Officer OPT+S $241.10 13,468 $3,247,166 652
2024-02-21 01:32 2024-02-15 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Parisotto Shannon M Officer OPT+S $241.20 5,882 $1,418,767 2,596
2024-02-21 01:20 2024-02-15 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. LaPlume Joseph W Officer SELL $238.93 838 $200,223 24,620
2024-02-07 23:07 2024-02-06 FOXO FOXO TECHNOLOGIES INC. WARD MARTIN CHRISTOPHER Officer, 10% owner SELL $0.42 250,000 $105,000 0
2024-02-07 23:07 2024-02-06 FOXO FOXO TECHNOLOGIES INC. WHITE MARK BRIAN Director, Officer, 10% owner SELL $0.42 250,000 $105,000 0
2024-01-31 00:30 2024-01-26 MXCT MAXCYTE, INC. Johnston John Joseph Director OPT+S $5.12 5,000 $25,585 120,583
2024-01-26 00:19 2019-06-07 NOTV Inotiv, Inc. Leasure Robert Jr. Director, Officer BUY $1.98 7,500 $14,864 105,000
2024-01-09 01:14 2024-01-04 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $40.85 7,214 $294,709 3,831,362
2024-01-06 00:25 2024-01-03 NRC NATIONAL RESEARCH CORP Common Property Trust 10% owner SELL $41.53 364,625 $15,142,876 4,452,937
2024-01-05 20:27 2024-01-03 INCY INCYTE CORP Stein Steven H Officer SELL $65.51 7,365 $482,481 90,218
2024-01-05 01:08 2024-01-02 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $40.86 321,239 $13,124,990 3,838,576
2024-01-04 21:05 2024-01-02 INCY INCYTE CORP Iyengar Vijay K Officer SELL $65.00 657 $42,705 43,412
2023-12-29 00:30 2023-12-26 MXCT MAXCYTE, INC. Johnston John Joseph Director OPT+S $4.53 5,000 $22,650 120,583
2023-12-19 01:03 2023-12-14 MEDP Medpace Holdings, Inc. BURWIG SUSAN E Officer SELL $303.96 12,400 $3,769,150 15,283
2023-12-19 00:07 2023-12-14 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Creamer Victoria L Officer OPT+S $225.00 5,526 $1,243,350 16,506
2023-12-16 01:33 2023-12-14 NOTV Inotiv, Inc. Garrett Michael Officer BUY $2.83 5,000 $14,145 16,467
2023-12-16 01:33 2023-12-14 NOTV Inotiv, Inc. Beattie John Gregory Officer BUY $3.12 47,966 $149,836 111,761
2023-12-14 22:11 2023-12-12 INCY INCYTE CORP Tray Thomas Officer SELL $61.55 1,277 $78,594 23,436
2023-12-15 01:17 2023-12-12 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $41.55 26,263 $1,091,264 4,159,815
2023-12-13 23:25 2023-12-12 OABI OmniAb, Inc. FOEHR MATTHEW W Director, Officer BUY $5.05 200,000 $1,010,000 2,645,442
2023-12-12 01:52 2023-12-07 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $41.55 54,704 $2,273,208 4,186,078
2023-12-07 01:59 2023-12-04 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $41.60 2,550 $106,080 4,240,782
2023-12-07 00:15 2023-12-04 MXCT MAXCYTE, INC. Doerfler Douglas Director, Officer OPT+S $5.14 124,450 $639,399 333,197
2023-12-06 01:01 2023-12-01 IQV IQVIA HOLDINGS INC. Knightly Kevin C Officer OPT+S $214.03 13,117 $2,807,472 7,347
2023-12-02 00:26 2023-11-29 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $272.86 53,167 $14,507,100 5,589,947
2023-12-02 00:25 2023-11-29 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $272.86 53,167 $14,507,100 5,589,947
2023-12-02 01:14 2023-11-29 MXCT MAXCYTE, INC. Doerfler Douglas Director, Officer OPT+S $5.00 25,550 $127,750 333,197
2023-12-02 00:10 2023-11-30 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. LaPlume Joseph W Officer SELL $197.73 1,850 $365,801 23,133
2023-11-30 00:16 2023-11-27 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $274.96 46,833 $12,877,319 5,643,114
2023-11-30 00:17 2023-11-27 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $274.96 46,833 $12,877,319 5,643,114
2023-11-30 00:36 2023-11-27 MXCT MAXCYTE, INC. Johnston John Joseph Director OPT+S $4.59 5,000 $22,950 120,583
2023-11-28 00:42 2023-11-22 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $277.81 25,000 $6,945,250 5,689,947
2023-11-28 00:40 2023-11-22 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $277.81 25,000 $6,945,250 5,689,947
2023-11-23 01:02 2023-11-20 NRC NATIONAL RESEARCH CORP Amandla MK Trust 10% owner SELL $42.07 784 $32,987 4,243,332
2023-11-23 00:15 2023-11-21 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $277.37 25,000 $6,934,250 5,714,947
2023-11-23 00:16 2023-11-21 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $277.37 25,000 $6,934,250 5,714,947
2023-11-22 00:16 2023-11-17 MEDP Medpace Holdings, Inc. Troendle August J. Director, Officer, 10% owner SELL $274.68 100,000 $27,468,000 5,739,947
2023-11-22 00:17 2023-11-17 MEDP Medpace Holdings, Inc. Medpace Investors, LLC 10% owner SELL $274.68 100,000 $27,468,000 5,739,947
2023-11-22 01:07 2023-11-20 CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Girshick Birgit Officer BUY $187.82 1,322 $248,298 44,449
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Services-Commercial Physical & Biological Research sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8731) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Services-Commercial Physical & Biological Research

Every transaction in the Services-Commercial Physical & Biological Research industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.